Menu
A Phase 3, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Eosinophilic Esophagitis.
The purpose of this study is to see if CC-93538 is safe and effective as a possible treatment for EoE. To do this, a comparison will be made between participants who receive CC-93538 and participants who receive a placebo (a ‘dummy treatment’ that looks like CC-93538 but contains no active ingredient).
You may be eligible for the study if you meet the following criteria.
To register for future studies in EoE, please add your details to the form below and we will contact you when a new clinical trial becomes available.
Please contact CDH Research Institute on 07 5408 0900 for additional information or use the email link below. You can also share details of this study to social media via the links below?
Clinical trials are important because they serve as the foundation for most medical advances.